Knowledge Distillery

Acute delirium and other neuropsychiatric symptoms have frequently been reported in COVID-19 patients and are variably referred to as acute…

This review focuses on new evidence supporting the global immunization strategy for MS patients receiving disease-modifying drugs (DMDs), including…

The purpose of this review was to provide an overview on current knowledge of neurological symptoms and complications of COVID-19, and to suggest…

The aim of this retrospective, international multicenter study was to assess the association between abnormal findings on chest and brain imaging in…

Whether and how SARS-CoV-2 outbreak affected in-hospital acute stroke care system is still matter of debate.

The objective of this prospective, multicentre, observational cohort study was to assess neurological manifestations and quality of life (QoL) three…

Coronavirus disease have been reported to be associated with several neurological manifestations such as stroke, Guillain-Barré syndrome,…

Emergence of SARS-CoV-2 causing COVID-19 prompted the need to gather information on clinical outcomes and risk factors associated with morbidity and…

This nationwide study assessed the impact of the pandemic on stroke hospitalisation rates, patient characteristics, and 30‐day case fatality rates.

The effects of the COVID‐19 pandemic on telemedical care have not been described on a national level.

The authors conducted a longitudinal case-control 18F-FDG-PET study in patients diagnosed with COVID-19-related encephalopathy.

The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length SARS-CoV-2 spike protein in a…